Ledger.Open graph →
SEC Form D · filed February 11, 2019

Aldeyra Therapeutics, Inc

Offering
$25.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Todd C. Brady · Lexington, MAExec · DirectorJesse I. Treu · Lexington, MADirectorBen J. Bronstein · Lexington, MADirectorGary J. Phillips · Lexington, MADirectorNeal J. Walker · Lexington, MADirectorMartin J. Joyce · Lexington, MADirectorJoshua Reed · Charleston, MDExecNicholas L. Lane · Road Town, Tortola, British Virgin IslandsDirectorMartin J. Joyce · Lexington, MADirectorNancy Kukacka · SAN FRANCISCO, CADirectorJesse I. Treu · Lexington, MADirectorRichard I. Douglas · Lexington, MADirectorDavid L. Clark · Lexington, MAExecDavid L. Mcmullin · Lexington, MAExecStephen I. Machatha · Lexington, MAExecScott L. Dakers · Grand Cayman, Cayman IslandsDirectorMichael J. Howe · Philadelphia, PAExec · DirectorDavid A. Achey · Philadelphia, PADirectorJoseph M. Manko, Jr · Philadelphia, PADirectorBradley D. Ginesin · Kent Cliffs, NYExec · DirectorBen J. Bronstein · Lexington, MADirectorRichard I. Douglas · Lexington, MADirectorDavid L. Clark · Lexington, MAExecDavid L. Mcmullin · Lexington, MAExecStephen I. Machatha · Lexington, MAExecJoshua Reed · Charleston, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗